Evidence map›Paper›PMID 22527064›Full record

ReviewIntensive care medicine2012

An overview of anthrax infection including the recently identified form of disease in injection drug users.

Caitlin W Hicks, Daniel A Sweeney, Xizhong Cui, Yan Li, Peter Q Eichacker

Abstract readReview
In one paragraph

Review in Intensive care medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Anthrax: A narrative review.New microbes and new infections · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Histologic Changes In Recreational Drug Misuse.Academic forensic pathology · 2018
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Caitlin W HicksCleveland Clinic Lerner College of Medicine, Cleveland, OH 44122, USA.
Daniel A Sweeney
Xizhong Cui
Yan Li
Peter Q Eichacker
National Institutes of Health Clinical Center · USCleveland Clinic Lerner College of Medicine · USWashington Hospital · US

Funding

Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

purposeBacillus anthracis infection (anthrax) can be highly lethal. Two recent outbreaks related to contaminated mail in the USA and heroin in the UK and Europe and its potential as a bioterrorist weapon have greatly increased concerns over anthrax in the developed world.

methodsThis review summarizes the microbiology, pathogenesis, diagnosis, and management of anthrax. RESULTS AND

conclusionsAnthrax, a gram-positive bacterium, has typically been associated with three forms of infection: cutaneous, gastrointestinal, and inhalational. However, the anthrax outbreak among injection drug users has emphasized the importance of what is now considered a fourth disease form (i.e., injectional anthrax) that is characterized by severe soft tissue infection. While cutaneous anthrax is most common, its early stages are distinct and prompt appropriate treatment commonly produces a good outcome. However, early symptoms with the other three disease forms can be nonspecific and mistaken for less lethal conditions. As a result, patients with gastrointestinal, inhalational, or injectional anthrax may have advanced infection at presentation that can be highly lethal. Once anthrax is suspected, the diagnosis can usually be made with gram stain and culture from blood or tissue followed by confirmatory testing (e.g., PCR). While antibiotics are the mainstay of anthrax treatment, use of adjunctive therapies such as anthrax toxin antagonists are a consideration. Prompt surgical therapy appears to be important for successful management of injectional anthrax.

Indexed as

AnthraxAntibiotic ProphylaxisAnti-Infective AgentsBacillus anthracisBioterrorismCiprofloxacinClindamycinDoxycyclineHumansPenicillinsSubstance Abuse, IntravenousAnti-Infective AgentsCiprofloxacinClindamycinDoxycyclinePenicillins

Identifiers

PMID22527064
PMCPMC3523299
OpenAlexW1977508498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.